DanielSofferMD
Cardiology • Jacksonville, FLAdult Congenital Heart Disease, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Preventive Cardiology
Senior Faculty, Interventional Cardiology University of Florida-Jacksonville, Florida Associate Professor of Medicine Director, Endovascular Cardiology
Dr. Soffer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UF Health Jacksonville, Florida
655 West Eighth Street
Jacksonville, FL 32209Phone+1 904-244-3378Fax+1 904-244-3102
Education & Training
Corewell Health William Beaumont University HospitalFellowship, Interventional Cardiology, 2000 - 2002
Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalFellowship, Cardiovascular Disease, 1997 - 2000- Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Internal Medicine, 1994 - 1997
Ben Gurion University of the NegevClass of 1993
Certifications & Licensure
FL State Medical License 2015 - 2027
NY State Medical License 2002 - 2017
NC State Medical License 2002 - 2006
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- Fellow FSCAI Society of Coronary Angiography and Interventions
- Fellow (FACC) American College of Cardiology, 2002
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 1 citationsClopidogrel-Mediated P2YInhibition According to Renal Function in Patients With Diabetes Mellitus and CAD.Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Mattia Galli, Latonya Been
JACC. Basic to Translational Science. 2024-07-01 - 4 citationsP2YInhibition in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention: The SWAP-AC-2 Study.Luis Ortega-Paz, Wilbert Bor, Francesco Franchi, Wout W A van den Broek, Fabiana Rollini
JACC. Cardiovascular Interventions. 2024-06-10 - 6 citationsSwitching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti...Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Mattia Galli, Latonya Been
Thrombosis and Haemostasis. 2024-03-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
